SCHEMBL4622471

SCHEMBL4622471

COC(=O)[C@]1(Br)CCCCCC1=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.39
CYP2C19 P33261 4/20 0.36
TSHR P16473 2/20 0.34
MAPT P10636 3/20 0.34
HSD11B1 P28845 1/20 0.34
CYP3A4 P08684 3/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
HTT P42858 1/20 0.33
CYP2C9 P11712 1/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4053114 0.98 NPSR1 (0.40) NPSR1CYP2C19TSHRMAPTHSD11B1
SCHEMBL3670181 0.93 CYP2C19 (0.41) NPSR1CYP2C19TSHRMAPTCYP3A4
SCHEMBL13009913 0.79 CYP2C19 (0.41) NPSR1CYP2C19TSHRMAPTCYP3A4
SCHEMBL4554424 0.79 CYP2C19 (0.41) NPSR1CYP2C19TSHRMAPTCYP3A4
SCHEMBL12083404 0.76 NPSR1 (0.40) NPSR1CYP2C19TSHRMAPTHSD11B1
SCHEMBL9583269 0.75 NPSR1 (0.39) NPSR1CYP2C19TSHRMAPTHSD11B1
SCHEMBL30153499 0.75 NPSR1 (0.39) NPSR1CYP2C19TSHRMAPTHSD11B1
SCHEMBL28078638 0.75 AKR1C1 (0.32) CYP2C19
SCHEMBL7550154 0.74 NPSR1 (0.41) NPSR1CYP2C19TSHRMAPTHSD11B1
SCHEMBL12083349 0.74 NPSR1 (0.41) NPSR1CYP2C19TSHRMAPTHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1793817-A4 METHODS OF TREATING A DISORDER ELIXIR PHARMACEUTICALS INC (US) 2008-04-02 EP disclosed
EP-1793817-A2 METHODS OF TREATING A DISORDER Elixir Pharmaceuticals, Inc. (US) 2007-06-13 EP disclosed
WO-2006031894-A2 METHODS OF TREATING A DISORDER ELIXIR PHARMACEUTICALS, INC. (US) 2006-03-23 WO disclosed